Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT02598193 · COMPLETED
Trial details
- NCT number
- NCT02598193
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-14
- Primary completion
- 2017-05-16
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.